|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12,410 KRW | -0.16% |
|
+0.49% | -3.57% |
| 2023 | JW Lifescience Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
| 2022 | JW Lifescience Corporation(KOSE:A234080) dropped from S&P Global BMI Index | CI |
JW Lifescience Corporation reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was KRW 1,546.8 million compared to KRW 2,485.83 million a year ago. Net income was KRW 7,660.96 million compared to KRW 4,633.53 million a year ago.
Basic earnings per share from continuing operations was KRW 495 compared to KRW 297 a year ago. Basic earnings per share was KRW 495 compared to KRW 297 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -3.57% | 142M | |
| +21.85% | 546B | |
| -4.77% | 359B | |
| +16.97% | 323B | |
| +5.69% | 290B | |
| +13.68% | 234B | |
| +3.65% | 198B | |
| -11.12% | 194B | |
| +8.08% | 167B | |
| -3.40% | 157B |
JW LIFESCIENCE CORPORATION 
